Hopeful,
Thank you for this article, I am eager for treatment to finally move in the direction of subtype and not size of tumor.
"However, when examined as single factors, neither nodal status nor tumor size predict survival"
So true, but I have to wonder when will the onc. who are treating
bc patients will begin to believe that subtype, HER2 status, must
be taken into strong consideration. The sea is still divided with much
debate.
Kind Regards,
jean
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006
|